Form 4 for TNXP Tonix Pharmaceuticals Holding Corp.
Accepted 2025-02-28 00:00:00 ET · period of report 2024-06-10 · accession 0001839882-25-012471 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-28 | 2024-06-10 | TNXP | OLUKOTUN ADEOYE Y | Dir | J - Other | $1.91 | -0.81 | 0 | -100% | -$1.55 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 | 2024-06-10 | J | D | 0.81 | $1.91 | 0 | D | — | — |